These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 25950807)

  • 41. Controversies in juvenile idiopathic arthritis-associated uveitis.
    Zierhut M; Heiligenhaus A; deBoer J; Cunningham ET; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2013 Jun; 21(3):167-79. PubMed ID: 23713826
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The management of myasthenia gravis in pregnancy.
    Ciafaloni E; Massey JM
    Semin Neurol; 2004 Mar; 24(1):95-100. PubMed ID: 15229796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Uveitis in children: about 20 cases].
    Laghmari M; Karim A; Guedira K; Ibrahimy W; Dahreddine M; Essakalli NH; Mohcine Z
    J Fr Ophtalmol; 2003 Jun; 26(6):609-13. PubMed ID: 12910201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Uveitis research 1963-1993. 1993 Bruppach Lecture of the Zurich University].
    Martenet AC
    Klin Monbl Augenheilkd; 1994 Jul; 205(1):3-13. PubMed ID: 7933906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ulcerative colitis practice guidelines in adults.
    Eugene C
    Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):10-2. PubMed ID: 22138063
    [No Abstract]   [Full Text] [Related]  

  • 46. Practical concepts in the management of uveitis.
    Biswas J
    Indian J Ophthalmol; 1993 Oct; 41(3):133-41. PubMed ID: 8125548
    [No Abstract]   [Full Text] [Related]  

  • 47. Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
    Zulian F; Balzarin M; Falcini F; Martini G; Alessio M; Cimaz R; Cimino L; Zannin ME
    Arthritis Care Res (Hoboken); 2010 Jun; 62(6):821-5. PubMed ID: 20191477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Role of the Message Convergence Framework in Medical Decision Making.
    Anthony KE; Sellnow TL
    J Health Commun; 2016; 21(2):249-56. PubMed ID: 26192458
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.
    Yates WB; Vajdic CM; Na R; McCluskey PJ; Wakefield D
    Ophthalmology; 2015 Feb; 122(2):265-73. PubMed ID: 25312044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Uveitis: RESULTS of a prospective randomized clinical and immunological study].
    Medzhidova SR
    Vestn Oftalmol; 2016; 132(1):15-22. PubMed ID: 27030429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uveitis and gender: the course of uveitis in pregnancy.
    Chiam NP; Lim LL
    J Ophthalmol; 2014; 2014():401915. PubMed ID: 24683491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacotherapy for uveitis: current management and emerging therapy.
    Barry RJ; Nguyen QD; Lee RW; Murray PI; Denniston AK
    Clin Ophthalmol; 2014; 8():1891-911. PubMed ID: 25284976
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Misapplication of Severity-of-Illness Scores toward Clinical Decision Making.
    Moskowitz A; Andersen LW; Cocchi M; Donnino MW
    Am J Respir Crit Care Med; 2016 Aug; 194(3):256-8. PubMed ID: 27299379
    [No Abstract]   [Full Text] [Related]  

  • 54. Essential laboratory tests in uveitis.
    Becker MD; Rosenbaum JT
    Dev Ophthalmol; 1999; 31():92-108. PubMed ID: 10641202
    [No Abstract]   [Full Text] [Related]  

  • 55. A call for inaction.
    Miller S
    Br J Gen Pract; 2015 Sep; 65(638):481. PubMed ID: 26324488
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treatment Concepts for Patients with Non-infectious Uveitis].
    Cursiefen C; Heiligenhaus A
    Klin Monbl Augenheilkd; 2018 May; 235(5):551-552. PubMed ID: 29739024
    [No Abstract]   [Full Text] [Related]  

  • 57. [Masquerades and Trojans : When tumors disguise as uveitis].
    Grajewski RS; Heindl LM
    Ophthalmologe; 2016 Dec; 113(12):1091. PubMed ID: 27873062
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of severe non-infectious uveitis in high-risk conditions (Part I): pregnancy and malignancies, management and safety issues.
    Cordero-Coma M; Salazar-Méndez R; Yilmaz T
    Expert Opin Drug Saf; 2015 Jul; 14(7):1071-86. PubMed ID: 25950807
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of severe non-infectious uveitis in high-risk conditions (Part 2): systemic infections; management and safety issues.
    Cordero-Coma M; Salazar-Méndez R; Yilmaz T
    Expert Opin Drug Saf; 2015; 14(9):1353-71. PubMed ID: 26118392
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Uveitis management: a multidisciplinary approach to assess systemic involvement and side effects of treatments.
    Peretz A; Guillaume MP; Casper-Velu L
    Acta Clin Belg; 2002; 57(3):142-7. PubMed ID: 12212355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.